Folgen
John F Kearney
John F Kearney
Professor of Microbiology, University of Alabama at Birmingham
Bestätigte E-Mail-Adresse bei uab.edu
Titel
Zitiert von
Zitiert von
Jahr
AC133, a novel marker for human hematopoietic stem and progenitor cells.
BDW Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG ...
Blood 90 (12), 5002-12, 1997
2598*1997
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines
JF Kearney, A Radbruch, B Liesegang, K Rajewsky
The Journal of Immunology 123 (4), 1548-1550, 1979
23411979
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
F Martin, AM Oliver, JF Kearney
Immunity 14 (5), 617-629, 2001
13352001
Marginal-zone B cells
F Martin, JF Kearney
Nature Reviews Immunology 2 (5), 323-335, 2002
11382002
Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.
DG Bole, LM Hendershot, JF Kearney
The Journal of cell biology 102 (5), 1558-1566, 1986
11011986
Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses
M Balázs, F Martin, T Zhou, JF Kearney
Immunity 17 (3), 341-352, 2002
8242002
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines
GD Yancopoulos, SV Desiderio, M Paskind, JF Kearney, D Baltimore, ...
Nature 311 (5988), 727-733, 1984
8141984
PI3 kinase signals BCR-dependent mature B cell survival
L Srinivasan, Y Sasaki, DP Calado, B Zhang, JH Paik, RA DePinho, ...
Cell 139 (3), 573-586, 2009
7782009
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency
W Schuler, IJ Weiler, A Schuler, RA Phillips, N Rosenberg, TW Mak, ...
Cell 46 (7), 963-972, 1986
6661986
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
DE Briles, M Nahm, K Schroer, J Davie, P Baker, J Kearney, R Barletta
The Journal of experimental medicine 153 (3), 694-705, 1981
6001981
B‐cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”
F Martin, JF Kearney
Immunological reviews 175 (1), 70-79, 2000
5562000
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses
AM Oliver, F Martin, GL Gartland, RH Carter, JF Kearney
European journal of immunology 27 (9), 2366-2374, 1997
5521997
Autoreactivity by design: innate B and T lymphocytes
A Bendelac, M Bonneville, JF Kearney
Nature Reviews Immunology 1 (3), 177-186, 2001
5482001
B1 cells: similarities and differences with other B cell subsets
F Martin, JF Kearney
Current opinion in immunology 13 (2), 195-201, 2001
5362001
IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells
AM Oliver, F Martin, JF Kearney
The Journal of Immunology 162 (12), 7198-7207, 1999
4951999
Developmentally controlled expression of immunoglobulin VH genes
RM Perlmutter, JF Kearney, SP Chang, LE Hood
Science 227 (4694), 1597-1601, 1985
4591985
Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.
L Hendershot, D Bole, G Köhler, JF Kearney
The Journal of cell biology 104 (3), 761-767, 1987
4521987
Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk
F Martin, JF Kearney
Immunity 12 (1), 39-49, 2000
4322000
B lymphocyte differentiation induced by lipopolysaccharide: I. Generation of cells synthesizing four major immunoglobulin classes
JF Kearney, AR Lawton
The Journal of Immunology 115 (3), 671-676, 1975
426*1975
Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells
K Attanavanich, JF Kearney
The Journal of Immunology 172 (2), 803-811, 2004
3912004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20